Pfiz­er los­es ap­peal over co-pay help for $225,000 per year heart drug

The Sec­ond Cir­cuit ap­peals court on Mon­day sided with the HHS in­spec­tor gen­er­al and con­firmed a dis­trict court’s de­ci­sion that Pfiz­er can­not help pa­tients with …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER